EHMTI-0340. Distance treatment programs for individuals with complex chronic headaches living far from the hospital: the Canadian experience
- 378 Downloads
KeywordsEmotional Regulation Tertiary Care Hospital Chronic Headache Physiological Arousal Cognitive Reappraisal
Individuals far from treatment centres are at increased risk of unmet needs. Given the high prevalence of headache, this is a great concern. With increased communication technology advancements including telehealth comes the opportunity to treat remote patients with limited or no access.
To compare the efficacy of the Pain 101 program in headache patients who attend the program in person versus those who attend via telehealth.
To discuss qualitative aspects of telehealth use reported by patients and staff.
Adolescent and adult outpatients with complex headaches referred to tertiary care hospitals were enrolled in Pain 101. This pain management program targets pain education, reducing physiological arousal, goal setting and activity management, cognitive reappraisal and acceptance, and emotional regulation.
Adult and pediatric patients showed significant and lasting reductions in pain, pain-related disability, anxiety, pain-related fear, and a significant improvement in sleep and quality of life. Adults but not pediatric patients showed depression reduction. No significant differences were found between patients who attended via telehealth compared to those attending in person. Cost saving estimates to individual patients ranged from 1650–6600 Euro. Qualitatively, several patients reported that they would not have been able to attend without telehealth. Common complaints regarding telehealth were occasional technical difficulties and not feeling as involved in the group process.
Strong support for telehealth technology was found for individuals with complex headaches who live far from treatment centres. Recommendations for effective use of this technology for providing headache treatment will be discussed.
No conflict of interest.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.